Clinical Trial Update: A Study to Evaluate the Safety and Pharmacokinetics of UI087 Compared to Coadministration of UIC202506, UIC202507 and UIC202508 in Healthy Adult Volunteers Under Fasting Conditions [Phase 1]

View source ↗

Summary

Phase 1 study to evaluate the safety and pharmacokinetics of UI087 compared with coadministration of UIC202506, UIC202507, and UIC202508 in healthy adult volunt…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Type 2 Diabetes Mellitus

Drugs mentioned

• UI087
• UIC202506
• UIC202507
• UIC202508

Snippet

Sponsor: Korea United Pharm. Inc. | Conditions: Diabetes Mellitus (Type 2) | Phase 1 | Status: NOT_YET_RECRUITING